Cipher Pharmaceuticals Inc saw a notable increase in its stock price, closing up 3.03% in the last trading session.
In a positive turn for investors, Cipher Pharmaceuticals Inc (CPH.TO) experienced a 3.03% rise in its stock price, closing at CA$16.67. This uptick reflects growing investor confidence in the company's financial performance and market position.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Cipher Pharmaceuticals Inc
CPH.TO
CPH.TO
Cipher Pharmaceuticals Inc
WealthAwesomeMarket cap
$416.93M
P/E
9.8x
52W high
$20.56
52W low
$11.98
1W change
+0.31%
Beta
0.48
Analyst Price Targets
Based on analyst covering CPH
Wall Street analysts forecast CPH stock price to rise 25.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$20.64
+25.5% Upside
Current Price
C$16.44
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CPH's historical volatility
30-Day Vol
21.8%
Annualized
90-Day Vol
33.9%
Annualized
Trend (90d)
-44.6%
Annualized drift
90d Mean
C$14.02
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$15.59 | C$14.46 – C$16.81 |
| 60 trading days | C$14.79 | C$13.30 – C$16.44 |
| 90 trading days | C$14.02 | C$12.31 – C$15.97 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: As Cipher continues to demonstrate strong financial results, investors may find the recent stock price increase a promising sign of future growth.
Market Cap Reaches CA$410.83 Million
With a market cap of CA$410.83 million and a P/E ratio of 9.86, Cipher Pharmaceuticals is positioned attractively compared to industry peers, potentially drawing more investor interest.
Bull case
Cipher Pharmaceuticals has shown impressive financial growth, reporting a 25% year-over-year increase in adjusted EBITDA in its recent Q1 results. This trend suggests the company has a solid foundation for continued stock performance.
Bear case
Even with the recent positive movement, investors should be cautious. Market sentiment can shift quickly, and upcoming earnings reports could significantly impact stock performance.
Recent Financial Performance
Cipher Pharmaceuticals has reported substantial growth in its financial results, with a 25% increase in adjusted EBITDA and a 135% rise in net income in its latest quarterly report. Such strong performance metrics likely contribute to the current stock price increase.
Market Sentiment and Future Outlook
The positive movement in Cipher's stock price reflects broader market sentiment towards the pharmaceutical sector. Investors are optimistic about the company's ability to sustain growth, especially given its recent record revenue achievements. However, market dynamics can change, so investors should remain vigilant.
Advertisement
Wealth Awesome Newsroom
The Wealth Awesome Newsroom delivers timely Canadian market updates, earnings, dividends, and stock movers for DIY investors. Coverage is reviewed against public filings and market data feeds.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
